Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo
/in International Publications, Malignant Lymphoma /von 2007-11-09 / Blood 2008 Feb;111(3):1504-11Hyperthermia induces endoplasmic reticulum-mediated apoptosis in melanoma and non-melanoma skin cancer cells
/in Hyperthermia, International Publications, Malignant Melanoma /von 2007-11-08 / J. Invest. Dermatol. 2008 Apr;128(4):949-56Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2007-11-01 / Br. J. Haematol. 2007 Nov;139(3):415-24Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application
/in International Publications, Newcastle Disease Virus /von 2007-11-01 / Int. J. Oncol. 2007 Nov;31(5):1009-19[Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas]
/in Dendritic Cells, Glioblastoma, International Publications /von 2007-11-01 / Zhejiang Da Xue Xue Bao Yi Xue Ban 2007 Nov;36(6):592-7[Effects of intratumoral injection therapy of dendritic cells combined with hyperthermia for cancer patients]
/in Dendritic Cells, International Publications /von 2007-11-01 / Gan To Kagaku Ryoho 2007 Nov;34(12):1905-7Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2007-11-01 / Int J Hyperthermia 2007 Nov;23(7):591-8[The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo]
/in Colorectal Cancer, International Publications /von 2007-11-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Nov;23(11):1046-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution